Fluocinolone acetonide implant (FAci) one month after dexamethasone implant (DEXi) for chronic diabetic macular edema: 1-year results
Injection of FAci one month after DEXi in pseudophakic patients with chronic DME who responded previously to DEXi results in anatomical improvement and deferred visual gain. This prospective study demonstrates the efficacy and safety of both implants in DME patients who have been previously treated with other therapies.
Authors
- Thi Hà Châu Tran (ORCID: https://orcid.org/0000-0001-9066-7092)
- Benjamin Jany (ORCID: https://orcid.org/0000-0002-6934-6531)
- Q Lampin
- J Poret
- M Gherras
Institutions
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
Publication Details
- Journal
- Journal Français d Ophtalmologie
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1016/j.jfo.2024.104352
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00